Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Mar 29;9(3):137.
doi: 10.1038/s41424-018-0010-y.

Baclofen and gastroesophageal reflux disease: seeing the forest through the trees

John O Clarke  1 , Nielsen Q Fernandez-Becker  2 , Kirsten A Regalia  2 , George Triadafilopoulos  2
Affiliations
Editorial

Baclofen and gastroesophageal reflux disease: seeing the forest through the trees

John O Clarke et al. Clin Transl Gastroenterol. .

Abstract

Baclofen has been shown to decrease reflux events and increase lower esophageal sphincter pressure, yet has never established a clear role in the treatment of gastroesophageal reflux disease (GERD). Lei and colleagues have shown in a recent elegant study that baclofen reduces the frequency and initiation of secondary peristalsis and heightens esophageal sensitivity to capsaicin-mediated stimulation. These findings may help explain both the benefit of baclofen in conditions such as rumination and supragastric belching, as well as the apparent lack of benefit of baclofen and other GABAB agonists in long-term treatment of GERD.

PubMed Disclaimer

Conflict of interest statement

Guarantors of the article

John O. Clarke.

Specific authors contributions

J.O.C.: planning and drafting the manuscript; approval of final draft. N.Q.F.-B.: critical revision of the manuscript; approval of final draft. K.A.R.: critical revision of the manuscript; approval of final draft. G.T.: critical revision of the manuscript; approval of final draft.

Financial support

None.

Potential competing interests

None.

Comment on

References

    1. Locke GR, 3rd, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112:1448–1456. doi: 10.1016/S0016-5085(97)70025-8. - DOI - PubMed
    1. Sandler RS, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500–1511. doi: 10.1053/gast.2002.32978. - DOI - PubMed
    1. Scarpellini E, et al. Management of refractory typical GERD symptoms. Nat. Rev. Gastroenterol. Hepatol. 2016;13:281–294. doi: 10.1038/nrgastro.2016.50. - DOI - PubMed
    1. Savarino E, et al. Expert consensus document: advances in the physiological assessment and diagnosis of GERD. Nat. Rev. Gastroenterol. Hepatol. 2017;14:665–676. doi: 10.1038/nrgastro.2017.130. - DOI - PubMed
    1. Scarpellini E, et al. Effect of baclofen on gastric acid pocket in subjects with gastroesophageal reflux disease symptoms. Dis. Esophagus. 2016;29:1054–1063. doi: 10.1111/dote.12443. - DOI - PubMed